Bafna Pharmaceuticals P/B Ratio
Bafna Pharmaceuticals (BAFNAPH) P/B ratio is 9.19 (High), book value per share ₹255.00 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Review BAFNAPH price earnings ratio to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2020)
Valuation Signal
Sector Context
BAFNAPH P/B Ratio — Valuation Insights & Book Value Analysis
Bafna Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 9.19 (High). View Bafna Pharmaceuticals yearly highs lows for the annual high/low range and current price position.
- Stock appears overvalued with PB of 9.19, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1271.6% above historical average
- Trading at premium to sector average PB of -0.3
Bafna Pharmaceuticals P/B Ratio Historical Trend
BAFNAPH annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see BAFNAPH share price.
BAFNAPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Bafna Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2020 | 0.67 | ₹255.0 | ₹170.85 | ₹51 | Low |
BAFNAPH vs Healthcare Peers — P/B Ratio Comparison
Bafna Pharmaceuticals P/B 9.19 vs Healthcare average -0.3, median 0.6 — range -16.4–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -16.4 | ₹20 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |